Financials data is unavailable for this security.
View more
Year on year 60 Degrees Pharmaceuticals Inc had revenues fall -50.40% from 511.21k to 253.57k, though the company grew net income from a loss of 6.18m to a smaller loss of 3.77m.
Gross margin | 15.59% |
---|---|
Net profit margin | -366.89% |
Operating margin | -2,113.98% |
Return on assets | -27.71% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, 60 Degrees Pharmaceuticals Inc increased its cash reserves by 708.88%, or 1.88m. Cash Flow from Financing totalled 6.47m or 2,553.37% of revenues. In addition the company used 4.54m for operations while cash used for investing totalled 115.89k.
Cash flow per share | -2.92 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.98 |
---|---|
Tangible book value per share | 2.74 |
More ▼
Balance sheet in USDView more
Current ratio | 3.09 |
---|---|
Quick ratio | 2.74 |
Total debt/total equity | 0.0519 |
---|---|
Total debt/total capital | 0.0505 |
More ▼